Dr Gil Morgan from OncoAlert gives his oncology highlights from social media for the week of July 1 - July 10, 2021.
Alerts this week covers the US FDA approval for enfortumab vedotin for pretreated metastatic or advanced bladder cancer. Dr Morgan also discusses papers from Lancet Oncology, Journal of Clinical Oncology and IASLC.
In the end, Dr Morgan mentions the OncoAlert Colloquim which is coming in December this year.
You can watch Dr Morgan's previous roundup here.
Follow Dr Morgan on twitter: @OncoAlert
Follow ecancer on twitter: @ecancer